# Nico Vandervelpen

> Nico Vandervelpen is a Series A investor at Limburgse Reconversie Maatschappij backing Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Limburgse Reconversie Maatschappij](https://shizune.co/investors/profile/limburgse-reconversie-maatschappij)
- Total investments: 1
- Last investment: Jan 2013
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/nico-vandervelpen-7772814

Nico Vandervelpen is a Series A investor at Limburgse Reconversie Maatschappij focused on Health Care and Biotechnology. Nico Vandervelpen is the co-founder of Bioqube Ventures. Nico attended UHasselt.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| FF Pharma | FF Pharma, a biopharmaceutical company, develops anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The functions of CD40 in immune regulation suggest that the CD40 pathway may play a role in diseases in which anomalous immune responses, e.g. autoantibodyproduction or chronic inflammation, are a feature. | $4.2M | Series A | Jan 23, 2013 |  |

1 of 1 investments shown.

## Co-investors
- [PMV Pharmaceuticals](https://shizune.co/investors/profile/pmv-pharmaceutcals-inc) — VC Fund, 1 deal together
- [Vesalius Biocapital Partners](https://shizune.co/investors/profile/vesalius-biocapital-partners) — VC Fund, 1 deal together

## About Limburgse Reconversie Maatschappij

VC Fund · Hasselt, Belgium

LRM is an investment company that develops and stimulates economic growth in Limburg. We provide a solid foundation so that companies and projects that create jobs in Limburg can grow. Our financial resources and expertise, together with the assets of Limburg, provide a unique breeding ground.

5 contacts available at Limburgse Reconversie Maatschappij.

| Name | Title | Profile |
| --- | --- | --- |
| Inne Hesemans | Secretary of the Board | https://shizune.co/investors/profile/inne-hesemans |
| Koen Nulens | Senior Investment Manager | https://shizune.co/investors/profile/koen-nulens |
| Luc Driesen | Team Member | https://shizune.co/investors/profile/luc-driesen |
| Rik van Hensberg | Property Manager | https://shizune.co/investors/profile/rik-van-hensberg |
| Tom Aerts | Head of Technology & Services | https://shizune.co/investors/profile/tom-aerts |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Nico Vandervelpen invest in?

Nico Vandervelpen invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Nico Vandervelpen last invest?

The most recent investment recorded for Nico Vandervelpen closed in Jan 2013. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co